Literature DB >> 18955521

Tissue accumulation of cephalothin in burns: a comparative study by microdialysis of subcutaneous interstitial fluid cephalothin concentrations in burn patients and healthy volunteers.

Andrew J Dalley1, Jeffrey Lipman, Renae Deans, Bala Venkatesh, Michael Rudd, Michael S Roberts, Sheree E Cross.   

Abstract

Burn tissue sites are a potential source of bacteremia during debridement surgery. Burn injury is likely to affect the distribution of antibiotics to tissues, but direct evidence of this is lacking. The aim of this study was to directly evaluate the influence of burn trauma on the distribution of cephalothin to peripheral tissues. We used subcutaneous microdialysis techniques to monitor interstitial fluid concentrations of cephalothin in the burnt and nonburnt tissues of adult patients with severe burns following parenteral administration of 1 g cephalothin for surgical prophylaxis. Analogous simultaneous studies conducted with healthy adult volunteers provided reference tissue concentration data. Equivalent tissue exposures were seen for burn and nonburn sites, giving overall median interstitial cephalothin concentrations (from 0 to 240 min) of 2.84 mg/liter and 3.06 mg/liter, respectively. A lower overall median interstitial cephalothin concentration of 0.54 mg/liter was observed for healthy individuals, and the patient nonburnt tissue and volunteer control tissue cephalothin concentrations exhibited significantly different data distributions (P < 0.001; Kolmogorov-Smirnov nonparametric test). The duration of tissue residence for cephalothin was longer for burn patients than for healthy volunteers. The results demonstrate the potential fallibility of using healthy population models to extrapolate tissue pharmacodynamic predictions from plasma data for burn patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955521      PMCID: PMC2612177          DOI: 10.1128/AAC.00718-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Disposition of alfentanil in burns patients.

Authors:  A G Macfie; A D Magides; C S Reilly
Journal:  Br J Anaesth       Date:  1992-11       Impact factor: 9.166

Review 2.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method.

Authors:  M R Bouw; M Hammarlund-Udenaes
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

4.  Pharmacokinetics and tissue concentrations of ceftazidime in burn patients.

Authors:  R A Walstad; L Aanderud; E Thurmann-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 5.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Pharmacological principles of antibiotic prescription in the critically ill.

Authors:  M Pinder; R Bellomo; J Lipman
Journal:  Anaesth Intensive Care       Date:  2002-04       Impact factor: 1.669

7.  Diffusion of beta-lactam antibiotics and fosfomycin to interstitial tissue fluid in rabbits.

Authors:  M V Vicente; T Olay; M C Quecedo; A Rodríguez
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

8.  Plasma concentrations of tumour necrosis factor-alpha and interleukin-6 during burn wound surgery or dressing.

Authors:  R P Papini; A P Wilson; J A Steer; G Hill; D A McGrouther; N Parkhouse
Journal:  Br J Plast Surg       Date:  1997-07

Review 9.  Clinical pharmacokinetics in patients with burns.

Authors:  U Jaehde; F Sörgel
Journal:  Clin Pharmacokinet       Date:  1995-07       Impact factor: 6.447

Review 10.  Pathogenesis of edema formation in burn injuries.

Authors:  T Lund; H Onarheim; R K Reed
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

View more
  5 in total

Review 1.  Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization.

Authors:  Amelia N Deitchman; M Tobias Heinrichs; Vipada Khaowroongrueng; Satyawan B Jadhav; Hartmut Derendorf
Journal:  AAPS J       Date:  2016-12-09       Impact factor: 4.009

2.  Comparison of the pharmacokinetics of linezolid in burn and non-burn rabbits.

Authors:  Jian-Li Ma; Lei Gao; Xiang Li; Wan-Li Chu; Yong-Qiang Feng; Xiao-Qin Wang; Qing-Zhe Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-13       Impact factor: 2.441

3.  Unbound cephalothin pharmacokinetics in adult burn patients are related to the elapsed time after injury.

Authors:  Andrew J Dalley; Renae Deans; Jeffrey Lipman; Bala Venkatesh; Michael Rudd; Michael S Roberts; Sheree E Cross
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

4.  Measurement of tissue cortisol levels in patients with severe burns: a preliminary investigation.

Authors:  Jeremy Cohen; Renae Deans; Andrew Dalley; Jeff Lipman; Michael S Roberts; Bala Venkatesh
Journal:  Crit Care       Date:  2009-11-27       Impact factor: 9.097

Review 5.  Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.

Authors:  Rui Pedro Veiga; José-Artur Paiva
Journal:  Crit Care       Date:  2018-09-24       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.